These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1383888)
41. GluR2 protein synthesis and metabolism in rat hippocampus following transient ischemia and ischemic tolerance induction. Kjøller C; Diemer NH Neurochem Int; 2000 Jul; 37(1):7-15. PubMed ID: 10781841 [TBL] [Abstract][Full Text] [Related]
42. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes. Okada M; Kohara A; Yamaguchi T Eur J Pharmacol; 1996 Aug; 309(3):299-306. PubMed ID: 8874154 [TBL] [Abstract][Full Text] [Related]
43. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Lindvall O; Ernfors P; Bengzon J; Kokaia Z; Smith ML; Siesjö BK; Persson H Proc Natl Acad Sci U S A; 1992 Jan; 89(2):648-52. PubMed ID: 1731336 [TBL] [Abstract][Full Text] [Related]
44. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain. Dev KK; Petersen V; Honoré T; Henley JM J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496 [TBL] [Abstract][Full Text] [Related]
45. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats. Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741 [TBL] [Abstract][Full Text] [Related]
46. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord. Chizh BA; Cumberbatch MJ; Headley PM Br J Pharmacol; 1994 Jul; 112(3):843-6. PubMed ID: 7522860 [TBL] [Abstract][Full Text] [Related]
47. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia. DeGraba TJ; Ostrow P; Hanson S; Grotta JC J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322 [TBL] [Abstract][Full Text] [Related]
48. Effect of AMPA on cerebral cortical oxygen balance of ischemic rat brain. Narayanan U; Chi OZ; Liu X; Weiss HR Neurochem Res; 2000 Mar; 25(3):405-11. PubMed ID: 10761987 [TBL] [Abstract][Full Text] [Related]
49. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
50. AMPA receptor antagonists and local cerebral glucose utilization in the rat. Browne SE; McCulloch J Brain Res; 1994 Mar; 641(1):10-20. PubMed ID: 8019834 [TBL] [Abstract][Full Text] [Related]
51. NBQX reduces threshold of protein synthesis inhibition in focal ischaemia in rats. Kohno K; Mies G; Djuricic B; Hossmann KA Neuroreport; 1994 Nov; 5(17):2342-4. PubMed ID: 7881056 [TBL] [Abstract][Full Text] [Related]
52. GYKI 53665, a 2,3-benzodiazepine, non-competitively protects cultured neurones against AMPA toxicity. Kovács AD; Szabó G Eur J Pharmacol; 1997 Jul; 331(1):93-6. PubMed ID: 9274935 [TBL] [Abstract][Full Text] [Related]
53. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Wrathall JR; Teng YD; Marriott R Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092 [TBL] [Abstract][Full Text] [Related]
54. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Colbourne F; Li H; Buchan AM; Clemens JA Stroke; 1999 Mar; 30(3):662-8. PubMed ID: 10066868 [TBL] [Abstract][Full Text] [Related]
55. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339 [TBL] [Abstract][Full Text] [Related]
56. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats. Nakamura K; Kurasawa M; Shirane M Brain Res; 2000 Apr; 862(1-2):266-9. PubMed ID: 10799697 [TBL] [Abstract][Full Text] [Related]
57. Inflammation contributes to the postponed ischemic neuronal damage following treatment with a glutamate antagonist in rats. Block F; Bozdag I; Nolden-Koch M Neurosci Lett; 2001 Feb; 298(2):103-6. PubMed ID: 11163288 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of stress-induced adrenocorticotropin and prolactin secretion mediating hypophysiotropic factors by antagonist of AMPA type glutamate receptor. Kusakawa S; Tohei A; Jaroenporn S; Watanabe G; Taya K J Reprod Dev; 2007 Jun; 53(3):545-54. PubMed ID: 17272925 [TBL] [Abstract][Full Text] [Related]
59. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632 [TBL] [Abstract][Full Text] [Related]
60. Regulation of growth hormone secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in infantile, prepubertal, and adult male rats. González LC; Pinilla L; Tena-Sempere M; Aguilar E Endocrinology; 1999 Mar; 140(3):1279-84. PubMed ID: 10067854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]